Clinical Trials Directory

Trials / Terminated

TerminatedNCT04625426

Evaluation of Skin Cleansers and Skin Protectants in Management of Incontinence-associated Dermatitis

Evaluate the Efficacy of Two Advanced Skin Treatment Regimens in Treating Incontinence-associated Dermatitis: Cluster Randomization Study

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
86 (actual)
Sponsor
Tan Tock Seng Hospital · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the efficacy of two different skin care regimens (3M Cavilon Advanced Skin Protectant with 3M No-Rinse Cleanser and Coloplast Conveen Critic Barrier with Easi-Cleanser) against standard care (Skin wipes and Conveen Critic Barrier) in the management of Incontinence-Associated Dermatitis (IAD) in hospitalised patients

Detailed description

The aim of this study is to evaluate the efficacy of two different skin care regimens (3M Cavilon Advanced Skin Protectant with 3M No-Rinse Cleanser and Coloplast Conveen Critic Barrier with Easi-Cleanser) against standard care (Skin wipes and Conveen Critic Barrier) in the management of Incontinence-Associated Dermatitis (IAD) in hospitalised patients. To date, there is no conclusive evidence on the "best treatment" for patients presenting with IAD. This has led to current clinical practices tend to select IAD products based on its cost and availability, which can be heavily influenced by marketing and commercialisation efforts. This study allows investigation of the effectiveness of IAD products to ensure the provision of optimal care.

Conditions

Interventions

TypeNameDescription
DEVICE3M Cavilon No-Rinse Skin Cleanser and 3M Cavilon Advanced Skin ProtectantHypoallergenic no-rinse skin cleanser and liquid acrylic tetrapolymer skin protectant
DEVICEConveen EasiCleanse and Conveen Critic BarrierHypoallergenic no-rinse skin cleanser and zinc-oxide barrier cream
DEVICEStandard cleansing and Conveen Critic BarrierHospital's standard care for IAD management

Timeline

Start date
2019-04-29
Primary completion
2020-01-20
Completion
2020-09-30
First posted
2020-11-12
Last updated
2021-05-05
Results posted
2021-05-05

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT04625426. Inclusion in this directory is not an endorsement.